Recent Updates — BEATW
HeartBeam, Inc. entered into an At-The-Market Equity Offering Sales Agreement with Titan Partners Securities LLC on August 14, 2026. The agreement allows the company to sell up to $25,000,000 of its common stock from time to time through the sales agent. Shares may be sold at market prices via ordinary brokers' transactions or block trades under the company's existing shelf Registration Statement on Form S-3. The company will pay a commission of up to 3% of the gross sales price for shares sold through this arrangement. HeartBeam, Inc. operates in the healthcare technology industry, developing wearable cardiac monitoring devices.
Heartbeam, Inc. filed an amendment to disclose that former executive Robert P. Eno executed a Separation Agreement and Advisory Agreement on July 30, 2026. In exchange for a release of claims, Mr. Eno receives a $300,000 lump sum cash payment representing nine months of base salary, acceleration of all outstanding stock options and restricted stock units, an extension of post-termination exercise periods until December 31, 2027 or option expiration, up to nine months of COBRA premium reimbursement, and a $1,000 one-time advisory retainer fee. The company operates in the digital health industry, developing wearable cardiac monitoring devices.
HeartBeam, Inc. held its annual meeting of stockholders on July 31, 2026, with a record date of June 5, 2026. Seven directors were elected to one-year terms by ordinary majority vote: Richard Ferrari, Branislav Vajdic, George A. de Urioste, Marga Ortigas-Wedekind, Willem Elfrink, Kenneth Nelson, and Michael Jaff. The shareholders ratified the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026. However, a proposal to amend the 2022 Equity Incentive Plan to increase authorized shares by 3,000,000 was rejected. These are routine governance matters without material impact on value or operations. HeartBeam, Inc. operates in the medical device industry, developing wearable cardiac monitoring technology.